Loading...
•
Dec 31, 2025
Nutex Health Inc Q2 2025 Earnings Report
Nutex Health Inc Q4 and Full Year 2025 Earnings Report
Key Takeaways
Nutex Health reported record annual revenue of $875.3 million, an 82% increase year-over-year, driven significantly by its hospital division and success in the Independent Dispute Resolution (IDR) process. However, Q4 revenue saw a sharp decline due to a one-time $55 million arbitration true-up for ineligible claims. The company ended the year with a record cash balance of $185.6 million and authorized a new $25 million stock repurchase program.
Annual revenue grew 82.4% to $875.3 million, primarily fueled by the Hospital Division and high-acuity claims.
The company recorded a one-time $55 million negative revenue adjustment in Q4 2025 related to 18,950 ineligible arbitration claims.
Nutex Health remediated all previously disclosed material weaknesses in internal controls during the 2025 fiscal year.
A second stock repurchase program of up to $25 million was authorized to offset dilution from stock compensation obligations.
Forward Guidance
Nutex Health is focused on a balanced growth strategy involving de novo hospital development and increasing patient volumes at existing facilities, supported by a strong cash position and remediated internal controls.
Positive Outlook
- Planned growth through de novo hospital development
- Increasing patient volumes across existing facilities
- Strong balance sheet with $185.6 million in cash
- Successful remediation of all material weaknesses in internal controls
- Expansion of national footprint with three new micro-hospitals opened recently
Challenges Ahead
- Regulatory and litigation uncertainty under the No Surprises Act
- Potential dilution from stock compensation obligations for ramping hospitals
- Lawsuits filed by health insurance providers against third-party arbitration providers
- Impact of manipulative short seller reports
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...